---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-025104"
form_type: "8-K"
ticker: "AKTX"
cik: "0001541157"
company_name: "Akari Therapeutics Plc"
filed_at: "2025-08-21T23:59:59+00:00"
generated_at: "2026-05-17T10:49:49.513742+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Akari raises $2.26M via unsecured notes with 20% OID; Chairman Huh exchanges prior loan

## Summary
- Issued notes with aggregate purchase price of $2,261,000 and principal amount of $2,826,250; maturity 12 months from closing.
- Chairman Dr. Huh purchased $1,250,000 principal note for $1,000,000, paying $162,567 cash and cancelling $837,433 Peak Bio loan.
- Extended expiration of Series A Warrants on 1,973,211 ADSs by 48 months from original expiry.
- Paid Paulson Investment Company a 5% advisory fee ($70K) on ~$1.4M gross cash proceeds.
- Notes are unsecured; proceeds used for general corporate purposes.

## SEC filing metadata
- accession: 0001641172-25-025104
- form_type: 8-K
- ticker: AKTX
- cik: 0001541157
- company_name: Akari Therapeutics Plc
- filed_at: 2025-08-21T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1541157/000164117225025104/0001641172-25-025104-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1541157/000164117225025104/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-025104
- JSON: https://secwatch.observer/filing/0001641172-25-025104.json
- Plain text: https://secwatch.observer/filing/0001641172-25-025104.txt

## Key facts
- Debt Financings
  Akari Therapeutics Plc incurred debt of $2,826,250 maturing 12-month anniversary of the respective Closing Dates.
  - Principal: $2,826,250
  - Maturity: 12-month anniversary of the respective Closing Dates
  - Event: incurrence
  source text: the Company completed its first tranche of closings of the Offering and issued Notes with an aggregate purchase price of $2,261,000 and an aggregate principal amount of $2,826,250
  evidence_url: https://www.sec.gov/Archives/edgar/data/1541157/000164117225025104/0001641172-25-025104-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.